TIA
48
13
18
16
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.3%
4 terminated out of 48 trials
80.0%
-6.5% vs benchmark
21%
10 trials in Phase 3/4
25%
4 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (48)
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
The Stroke Aetiology and VascuLar Disease in Stroke and TIA Study - A Clinical Study Analysing the Effects on Cardiovascular Health and Disease With an Extended Investigation Into Conditions Causative of Stroke and Concomitant Cardiovascular Disease in Patients Admitted for Acute Stroke or TIA
Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation
Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
The Akershus Study of Ischemic Stroke and Thrombolysis -1
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA
Determining the MCID for the TOPICS-SF and PROMIS-10 in Older Patients That Suffered an Ischemic Stroke or TIA
Stroke Alarm Efficacy Trial
Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
Cilostazol and Aspirin in Stroke and TIA
Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)